Sign in
Groups
Researchers
Results
CELLULAR ONCOLOGY
Hospital de Sabadell
Barcelona, España
You are in
Collaborations
Hospital de Sabadell
Publications in collaboration with researchers from Hospital de Sabadell (1)
2017
Gemcitabine–erlotinib versus gemcitabine–erlotinib–capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group
European Journal of Cancer, Vol. 75, pp. 73-82
Contact
Legal notice
Help
translate
en
arrow_drop_down
translate
en
arrow_drop_down
es
eu
fr
de